XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Net Loss Per Share | 9 Months Ended
--- | ---
Jun. 30, 2024
Earnings Per Share [Abstract] |
Net Loss Per Share | NET LOSS PER SHARE The following table presents the computation of basic and diluted net loss per share for the three and nine months ended June 30, 2024 and 2023.
|  | Three Months Ended June 30, |  | Nine Months Ended June 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
|  | (in thousands, except per share amounts)
Numerator: |  |  |  |  |  |  |  |
Net loss attributable to Arrowhead Pharmaceuticals, Inc. |  | $ | (170,793) |  |  | $ | (102,946) |  |  | $ | (428,957) |  |  | $ | (95,596) |
Denominator: |  |  |  |  |  |  |  |
Weighted-average basic shares outstanding |  | 124,199 |  |  | 107,004 |  |  | 118,260 |  |  | 106,597 |
Effect of dilutive securities |  | — |  |  | — |  |  | — |  |  | — |
Weighted-average diluted shares outstanding |  | 124,199 |  |  | 107,004 |  |  | 118,260 |  |  | 106,597 |
Basic net loss per share |  | $ | (1.38) |  |  | $ | (0.96) |  |  | $ | (3.63) |  |  | $ | (0.90) |
Diluted net loss per share |  | $ | (1.38) |  |  | $ | (0.96) |  |  | $ | (3.63) |  |  | $ | (0.90) |
The following table sets forth the potentially dilutive securities that have been excluded from the calculation of diluted net loss per share because to include them would be anti-dilutive.
|  | Three Months Ended June 30, |  | Nine Months Ended June 30,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
|  | (in thousands)
Options |  | 753 |  |  | 637 |  |  | 711 |  |  | 768 |
Restricted stock units |  | 3,976 |  |  | 2,830 |  |  | 4,060 |  |  | 3,256 |
Total |  | 4,729 |  |  | 3,467 |  |  | 4,771 |  |  | 4,024 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration